Stephen Basil Thomas Eliem Therapeutics, Inc. (ELYM) insider trading activity

ELYM Quotes by TradingView

Stephen Basil Thomas is of Eliem Therapeutics, Inc.. Currently has a direct ownership of 103,907 shares of ELYM, which is worth approximately $427,057. The most recent transaction as insider was on Jun 27, 2024, when has been sold 103,907 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K
0% 3M change
n/a 12M change
Total Value Held $427,057

Stephen Basil Thomas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 27 2024
BUY
Grant, award, or other acquisition
-
103,907 Added 50.0%
103,907 Common Stock
SBT

Stephen Basil Thomas

Wilmington, DE

Track Institutional and Insider Activities on ELYM

Follow Eliem Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

News

Receive news related to Eliem Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELYM